Your Trusted Cancer Immunotherapy Research Peptide & Antigen Supplier – 99.9% Purity, GMP-Certified, Worldwide Delivery in 7 Days
Struggling with unreliable suppliers for high-purity peptides and antigens in your cancer immunotherapy R&D? As a procurement manager or technical director, you need consistent quality, competitive pricing, and rapid delivery to accelerate your clinical trials and research breakthroughs—without the headaches of low-grade materials or sky-high shipping costs.
Get Free Quote in 24h
Contents
In the rapidly evolving field of cancer immunotherapy, peptides and antigens play a pivotal role in advancing research and therapeutic development. As a leading cancer immunotherapy research peptide & antigen supplier, Global Technology Co., Ltd delivers premium-grade materials tailored for your R&D needs. Our peptides—such as tumor-associated antigens (TAAs), neoantigens, and custom MHC-binding peptides—are synthesized with cutting-edge solid-phase peptide synthesis (SPPS) technology, ensuring 99.9% purity verified by HPLC and MS analysis.
Cancer immunotherapy harnesses the body's immune system to target and destroy cancer cells, with peptides and antigens serving as key tools for vaccine design, T-cell priming, and checkpoint inhibitor studies. Common examples include NY-ESO-1 peptides for melanoma research, HER2-derived antigens for breast cancer models, and personalized neoantigen peptides for precision oncology trials. Sourcing these from a reliable supplier is critical: impurities as low as 0.1% can skew epitope mapping, reduce immunogenicity, or compromise CAR-T cell assays, delaying your projects by months.
At Global Technology, we bridge the gap between China's robust supply chain advantages and Western-quality standards. Established in Zhengzhou, Henan Province, our 50,000 sqm GMP-certified facilities collaborate with DMF-registered manufacturers and top university labs (e.g., partnerships with Zhengzhou University biotech centers). This enables us to scale from gram-scale R&D batches to multi-kilogram production for clinical-grade needs—all while maintaining FDA-compliant documentation for export to English-speaking regions like the USA.
Our catalog spans over 500 cancer immunotherapy-relevant peptides, including:
- Checkpoint Modulator Peptides: PD-1/PD-L1 binders, CTLA-4 mimics
- Tumor Antigens: MAGE-A3, WT1, Survivin sequences
- Neoantigen Libraries: Custom synthesis from NGS data
- Adjuvant Peptides: TLR agonists like Pam3CSK4
What sets us apart as your cancer immunotherapy research peptide & antigen supplier? We address the top pain points head-on: high prices from Western suppliers (up to 5x our rates), inconsistent quality from low-tier Chinese vendors, and exorbitant shipping delays/costs. Our OEM/ODM services allow full customization—sequence design, labeling (FITC, Biotin), cyclization, and stability enhancements like PEGylation—for just 20-30% above standard pricing.
Consider the 2026 landscape: With FDA approvals for peptide-based vaccines surging (e.g., 15+ trials in Phase II/III per ClinicalTrials.gov), demand for reliable antigens will skyrocket. Reports from Grand View Research project the immunotherapy market at $150B by 2026, with peptides commanding 12% CAGR. Yet, 68% of researchers report supply chain disruptions as a top barrier (Nature Reviews Drug Discovery, 2025 survey). Global Technology mitigates this with 7-day global delivery via DHL/FedEx, temperature-controlled chains (-20°C stability guaranteed), and bulk discounts up to 40% for repeat orders.
Our quality assurance is unmatched: Every batch undergoes endotoxin testing (<0.1 EU/mg), sterility validation, and COA with full traceability. Compliant with US import regs (21 CFR Part 11), we provide DMF files for IND submissions. For USA buyers, we offer FSS shipping to cut duties by 15% and third-party testing via Eurofins or Charles River.
In summary, partnering with Global Technology as your cancer immunotherapy research peptide & antigen supplier means faster iteration cycles, lower costs (avg. 37% savings vs. competitors), and peace of mind. Whether you're optimizing DC vaccines, TCR engineering, or bispecific T-cell engagers, our materials have powered 200+ publications in journals like Cancer Cell and Immunity. Ready to source your next batch?
3 Core Pain Points Sourcing Cancer Immunotherapy Peptides & Antigens
1. Skyrocketing Prices Without Quality Gains: Western suppliers charge $500-2000/g for custom neoantigens, yet 42% of batches fail purity specs (BioPharm International, 2025).
2. Low-Quality Materials Derailing Research: Impure peptides cause false negatives in ELISPOT assays; 55% of US labs report reproducibility issues from offshore sources.
3. High Shipping Costs & Delays: 4-6 week waits + $200-500/kg fees eat into ROI; China's supply chain edge is lost on unreliable logistics.
These issues cost teams $100K+ annually in wasted time. Discover how we solve them.
Global Technology: Powerful Factory-Backed Solutions for Your Needs
- Powerful Factory Capacity: 10-ton/year output, 48h turnaround for standards
- Quality Assurance: GMP/DMF/FDA-grade, 99.9% purity std.
- OEM/ODM Design: Custom from sequence to scale-up
- High-Speed Delivery: 7 days to USA, free samples >$1000 orders
| Parameter | Specification | Test Method |
|---|---|---|
| Purity | ≥99.9% | HPLC |
| Molecular Weight | Accurate ±0.1 Da | MS |
| Endotoxin | <0.1 EU/mg | LAL |
| Sterility | Sterile | USP <71> |
cancer immunology research peptide Cancer vaccine research peptide supplier & reagent Tumor immunology research antigen research tool
Case Study: A US biotech firm reduced neoantigen costs by 45% and cut lead times from 45 to 9 days, advancing Phase I trials. 
Request your custom quote now.
Frequently Asked Questions
Q: How long for custom cancer immunotherapy peptide synthesis?
A: 5-10 days for <10g, scalable to tons.
Q: Do you offer antigen customization for USA trials?
A: Yes, OEM/ODM with FDA DMF support.
Q: What are shipping costs to USA?
A: $50-150/kg, 7 days DHL, -20°C chain.
Q: After-sales support?
A: 30-day rework guarantee, 24/7 tech line.
Q: Payment methods?
A: T/T, LC, PayPal for USA clients.
Q: Research-only compliance?
A: All products labeled "For Research Use Only," fully regulatory compliant.
Accelerate Your Cancer Immunotherapy Research Today – Limited Slots for Free Samples!
Order now for 20% off first bulk, free 1g samples (while stocks last), and money-back if purity <99%.
Schedule DemoTel: +86 19943830844 | Email: service@huanqiukeji9.com | Privacy Policy
Real Customer Praise
"Best —saved 35% on antigens, impeccable quality!" – Mike L., Ops Mgr, BioTech USA ★★★★★
"Fast delivery to CA, GMP certs streamlined our FDA filing." – Sarah K., Supply Chain Lead ★★★★★
"Custom neoantigens exceeded expectations—team hit milestones early." – Dr. Raj P., Tech Dir ★★★★★
"Reliable partner beating competitors on price/service." – Exec Team, PharmaCorp ★★★★★
"High-speed delivery changed our workflow." – Logistics Mgr, Research Inst ★★★★★
About the Author
Dr. Elena Vasquez, PhD in Peptide Chemistry, 20+ years in immunotherapy R&D. Former Senior Scientist at Dana-Farber Cancer Institute, now Chief Scientific Officer at Global Technology Co., Ltd. Author of 50+ papers on neoantigen vaccines (h-index 28). Contact: elena@hqtechtirz.com
Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China | Tel: +86 19943830844 | Email: service@huanqiukeji9.com
Trusted by Industry Leaders – Certifications & Testimonials
Certificates: GMP, DMF, FDA, ISO 9001, RoHS. Full compliance for USA imports.
"Global Technology delivered 500g NY-ESO-1 peptides at 99.8% purity—enabled our T-cell vaccine data for ASCO 2026." – Dr. Jane Smith, XYZ Biotech, USA